Food and Beverage
CombinatoRx, Neuromed Shareholders Approve Merger
CAMBRIDGE, Mass. (AP) — Biotech drug developer CombinatoRx Inc. and Neuromed Pharmaceuticals Ltd. said Friday their shareholders approved the companies' proposed merger.
The all-stock transaction was announced in July and is expected to close Monday. Under the terms of the deal, CombinatoRx will issue about 36 million new shares of its common stock to Neuromed shareholders in a move that will give each side half of the voting power in the combined company. In July, the companies said final ownership will be determined by the outcome of the Food and Drug Administration review of Neuromed's extended-release opioid painkiller Exalgo. In June, Covidien, which is based in Ireland, bought the rights to Exalgo from Neuromed for an undisclosed amount. The drug is currently under FDA review. CombinatoRx is based in Cambridge, Mass. The company's stock rose a penny to $1.06 in afternoon trading. Neuromed is a privately held company based in Canada.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.03
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet